文献速递冠心病心力衰竭与心肌病

重新审视静脉-动脉体外膜氧合的作用:临床实践是否已超越证据?

Scrutinizing the Role of Venoarterial Extracorporeal Membrane Oxygenation: Has Clinical Practice Outpaced the Evidence?
PubMed 文献 · Circulation · 2024-03-25

本文综述静脉-动脉体外膜氧合(VA-ECMO)在临时机械循环支持中的应用现状,指出尽管临床应用持续增加,但缺乏足够证据。ARREST试验和PRAGUE OHCA二次分析支持院外心脏骤停中VA-ECMO的使用,而INCEPTION试验未发现体外心肺复苏改善短期死亡率。ECLS-SHOCK和ECMO-CS试验结果不支持在梗死相关心源性休克中常规使用VA-ECMO。正在进行的试验可能阐明特定亚组中的效用。

要点

  • VA-ECMO临床应用增加但缺乏充分随机对照试验证据。
  • 院外心脏骤停中证据不一:ARREST和PRAGUE OHCA支持,INCEPTION未显示短期死亡率改善。
  • 梗死相关心源性休克中ECLS-SHOCK和ECMO-CS试验不支持常规使用VA-ECMO。

核心结论

  • 在缺乏充分证据的情况下,VA-ECMO的当前使用是否改善结局仍不确定。

研究设计与样本

  • 本文为综述,检索并汇总了VA-ECMO在临时机械循环支持中的相关随机对照试验证据。

主要发现

  • ARREST试验和PRAGUE OHCA试验的二次分析提供了一些支持院外心脏骤停中VA-ECMO的证据。
  • INCEPTION试验未发现体外心肺复苏对短期死亡率有相关改善。
  • ECLS-SHOCK试验和ECMO-CS试验结果不支持在梗死相关心源性休克患者中常规使用VA-ECMO。

临床怎么用

  • 在等待进一步数据以优化患者选择和管理建议之前,VA-ECMO的临床应用需谨慎。

局限性

  • 缺乏足够效能的随机对照试验证据,现有试验结果不一致。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The use of venoarterial extracorporeal membrane oxygenation (VA-ECMO) for temporary mechanical circulatory support in various clinical scenarios has been increasing consistently, despite the lack of sufficient evidence regarding its benefit and safety from adequately powered randomized controlled trials. Although the ARREST trial (Advanced Reperfusion Strategies for Patients with Out-of-Hospital Cardiac Arrest and Refractory Ventricular Fibrillation) and a secondary analysis of the PRAGUE OHCA trial (Prague Out-of-Hospital Cardiac Arrest) provided some evidence in favor of VA-ECMO in the setting of out-of-hospital cardiac arrest, the INCEPTION trial (Early Initiation of Extracorporeal Life Support in Refractory Out-of-Hospital Cardiac Arrest) has not found a relevant improvement of short-term mortality with extracorporeal cardiopulmonary resuscitation. In addition, the results of the recently published ECLS-SHOCK trial (Extracorporeal Life Support in Cardiogenic Shock) and ECMO-CS trial (Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock) discourage the routine use of VA-ECMO in patients with infarct-related cardiogenic shock. Ongoing clinical trials (ANCHOR [Assessment of ECMO in Acute Myocardial Infarction Cardiogenic Shock, NCT04184635], REVERSE [Impella CP With VA ECMO for Cardiogenic Shock, NCT03431467], UNLOAD ECMO [Left Ventricular Unloading to Improve Outcome in Cardiogenic Shock Patients on VA-ECMO, NCT05577195], PIONEER [Hemodynamic Support With ECMO and IABP in Elective Complex High-risk PCI, NCT04045873]) may clarify the usefulness of VA-ECMO in specific patient subpopulations and the efficacy of combined mechanical circulatory support strategies. Pending further data to refine patient selection and management recommendations for VA-ECMO, it remains uncertain whether the present usage of this device improves outcomes.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Lüsebrink, Binzenhöfer, Hering, et al. Scrutinizing the Role of Venoarterial Extracorporeal Membrane Oxygenation: Has Clinical Practice Outpaced the Evidence? Circulation. 2024. PMID: 38527130. doi:10.1161/CIRCULATIONAHA.123.067087

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。